Abstract Background Ischemic stroke induced matrixmetallo-proteinase-9 (MMP-9) upregulation, which increased blood-brain barrier permeability. Studies demonstrated that mesenchymal stem cell therapy protected blood-brain barrier disruption from several cerebrovascular diseases. However, the underlying mechanism was largely unknown. We therefore hypothesized that mesenchymal stem cells reduced blood-brain barrier destruction by inhibiting matrixmetallo-proteinase-9 and it was related to intercellular adhesion molecule-1 (ICAM-1). Methods Adult ICR male mice (n = 118) underwent 90-min middle cerebral artery occlusion and received 2 × 105 mesenchymal stem cell transplantation. Neurobehavioral outcome, infarct volume, and blood-brain barrier pe...
Neuro-inflammation plays a key role in the pathophysiology of brain infarction. Cell therapy offers ...
Objective: Ischemic stroke is a major cause of death and prolonged disability worldwide. Inflammatio...
Stabilization of the blood-brain barrier during and after stroke can lead to less adverse outcome. F...
Ischemic stroke is the leading cause of mortality and long-term disability worldwide. Disruption of ...
Background/Aims: Stem cell treatment is one of the potential treatment options for ischemic stroke. ...
Neurodegenerative disorders encompass a broad spectrum of profoundly disabling situations that impac...
Objective: The mesenchymal stem cells derived from human amniotic membrane have the ability to secre...
AbstractTransplantation of mesenchymal stem cells (MSCs) has been shown to enhance the recovery of b...
BACKGROUND: Cerebral ischemia is usually characterized by a reduction in local blood flow and metabo...
The efficacy of mesenchymal stem cell (MSC) transplantation in ischemic stroke might depend on the t...
The role of the inducible matrix metalloproteinase (MMP)-9 in blood-brain barrier (BBB) disruption a...
Abstract Background Activated microglia-mediated neuroinflammation has been regarded as an underlyin...
Loss of vascular integrity and successive opening of the blood-brain barrier (BBB) are key compromis...
Objective Extracellular vesicles (EVs) derived from neural progenitor cells (NPCs) enhance post-stro...
Background: Ischemic stroke is a major cause of permanent disability and inflammation has a prominen...
Neuro-inflammation plays a key role in the pathophysiology of brain infarction. Cell therapy offers ...
Objective: Ischemic stroke is a major cause of death and prolonged disability worldwide. Inflammatio...
Stabilization of the blood-brain barrier during and after stroke can lead to less adverse outcome. F...
Ischemic stroke is the leading cause of mortality and long-term disability worldwide. Disruption of ...
Background/Aims: Stem cell treatment is one of the potential treatment options for ischemic stroke. ...
Neurodegenerative disorders encompass a broad spectrum of profoundly disabling situations that impac...
Objective: The mesenchymal stem cells derived from human amniotic membrane have the ability to secre...
AbstractTransplantation of mesenchymal stem cells (MSCs) has been shown to enhance the recovery of b...
BACKGROUND: Cerebral ischemia is usually characterized by a reduction in local blood flow and metabo...
The efficacy of mesenchymal stem cell (MSC) transplantation in ischemic stroke might depend on the t...
The role of the inducible matrix metalloproteinase (MMP)-9 in blood-brain barrier (BBB) disruption a...
Abstract Background Activated microglia-mediated neuroinflammation has been regarded as an underlyin...
Loss of vascular integrity and successive opening of the blood-brain barrier (BBB) are key compromis...
Objective Extracellular vesicles (EVs) derived from neural progenitor cells (NPCs) enhance post-stro...
Background: Ischemic stroke is a major cause of permanent disability and inflammation has a prominen...
Neuro-inflammation plays a key role in the pathophysiology of brain infarction. Cell therapy offers ...
Objective: Ischemic stroke is a major cause of death and prolonged disability worldwide. Inflammatio...
Stabilization of the blood-brain barrier during and after stroke can lead to less adverse outcome. F...